Position Summary
Cellares is seeking an innovative and highly motivated Director to lead enterprise client programs within the Process Development team. The candidate will have extensive experience in cell therapy manufacturing, personnel oversight and client relationship management. This individual will interface across many parts of the company and with customers to translate existing client drug product manufacturing processes onto the Cell Shuttle manufacturing platform.
The successful candidate will be responsible for managing and developing scientists and research associates, as well as supporting technology transfer and ongoing research and development activities. Extensive experience in experimental design, process development, process characterization, MSAT and cell/gene therapy manufacturing are required. The ideal candidate will be well acquainted with developing scalable processes and transferring them from the development space into manufacturing.
Candidates should enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows.
Cellares’ total compensation package contains competitive base salaries, highly subsidized Medical, Dental, and Vision Plans, 401(k) Matching, Free EV Charging, Onsite lunches, and Stock options. All displayed pay ranges are approximate, negotiable, and location dependent.
This is Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.
Leveling will be based on overall experience, education, and demonstration of knowledge throughout the interview process.